FULC vs XRAY · $427.0M cap vs rev $1.78B
Fulcrum Therapeutics Inc (FULC) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Fulcrum Therapeutics Inc (FULC) is a biotechnology company listed on US.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported FULC revenue for 2025-09-30 was $0. Net income was -$54.5M. FULC currently screens at market cap $427.0M.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
FULC currently screens at market cap $427.0M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the FULC and XRAY stock pages for the full models.
Not investment advice.